title: [The effect of a potential drug ingamine on a model of noninfectious pneumonia].
abstract: The potential drug ingamine (glutarylhistamine) showed pronounced anti-inflammatory activity on a model of acute noninfectious pneumonia and in the stage of chronic inflammation induced by singe instillation of Sephadex (5 mg/kg) in Wistar rats. A 6-day treatment with ingamine (50-500 microg/kg) by inhalation, intragastric, and intraperitoneal administration produced an anti-inflammatory effect (expressed to various degrees), which was manifested by a decrease in alveolitis, bronchitis, obstructive emphysema, lymphocyte-neutrophile infiltration of interalveolar septa, cytosis, and neutrophile component of bronchoalveolar lavage and by normalization of the cytogram. The most pronounced effect was observed upon inhalation in a dose of 500 microg/kg. In the stage of chronic inflammation, the inhalation of ingamine in a dose of 500 microg/kg produced a significant antiinflammatory action for both 10- and 20-day treatment. The effect was comparable with that of the inhaled glucocorticoid budesonide.
authors.forename: V L
authors.initials: VL
authors.lastname: Kovaleva
authors.forename: V E
authors.initials: VE
authors.lastname: Nebol'sin
authors.forename: O V
authors.initials: OV
authors.lastname: Makarova
authors.forename: E M
authors.initials: EM
authors.lastname: Noseĭkina
authors.forename: L P
authors.initials: LP
authors.lastname: Mikhaĭlova
mesh_terms: D000208:Acute Disease; D000280:Administration, Inhalation; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D006632:Histamine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008297:Male; D011014:Pneumonia / Q000139:chemically induced / Q000188:drug therapy*; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000893:Anti-Inflammatory Agents; C473189:N-glutarylhistamine; D006632:Histamine